Ardsley Advisory Partners’s AbbVie ABBV Stock Holding History

Ardsley Advisory Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-109,000	Closed	-$9.54M	–	129
2020 Q3	$9.54M	Sell	109,000 -121,500	-53%	-$11.4M	1.84%	19
2020 Q2	$22.6M	Buy	230,500 +141,500	+159%	+$12.5M	4.81%	3
2020 Q1	$6.77M	Buy	+89,000	New	+$7.58M	2.65%	13
2018 Q1	–	Sell	-207,500	Closed	-$20.1M	–	143
2017 Q4	$20.1M	Buy	207,500 +202,500	+4,050%	+$19.1M	2.44%	8
2017 Q3	$444K	Sell	5,000 -2,500	-33%	-$190K	0.06%	99
2017 Q2	$544K	Buy	+7,500	New	+$504K	0.08%	91
2014 Q4	–	Sell	-7,000	Closed	-$404K	–	185
2014 Q3	$404K	Hold	7,000	–	–	0.05%	133
2014 Q2	$395K	Hold	7,000	–	–	0.05%	181
2014 Q1	$360K	Hold	7,000	–	–	0.05%	165
2013 Q4	$370K	Buy	+7,000	New	+$344K	0.05%	111

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ardsley Advisory Partners's ABBV Position: Q4 2020 in Review

Ardsley Advisory Partners sold out of AbbVie (ABBV) in Q4 2020, closing a stake of 109,000 shares — an estimated $9.54M sold.

Ardsley Advisory Partners first reported a position in ABBV in Q4 2013 and held it in 10 quarters. The position peaked at $22.6M in Q2 2020. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Ardsley Advisory Partners reported no remaining AbbVie position as of Q4 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 109,000 AbbVie shares in Q4 2020, an estimated $9.54M.
Ardsley Advisory Partners first reported a position in AbbVie in Q4 2013 and held it in 10 quarters.
Ardsley Advisory Partners's AbbVie position peaked at $22.6M in Q2 2020.
2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Ardsley Advisory Partners's 13F filing for Q4 2020, filed 16 Feb 2021.